July 31, 2026

CorMedix Inc. (CRMD) Stock Analysis: Navigating a 100% Potential Upside in the Biotech Sector

CorMedix Inc. (NASDAQ: CRMD) is drawing significant attention in the biotechnology sector, and for good reason. With a compelling potential upside of 100.27%, this Parsippany, New..

uniQure N.V. (QURE) Stock Analysis: Assessing Upside Potential and Analyst Confidence in Biotech Innovator

uniQure N.V. (QURE) stands out in the biotechnology sector with its innovative approach to treating rare and devastating diseases. Headquartered in Amsterdam, the company is renowned..

Nutex Health Inc. (NUTX): Investor Outlook on an Expansive Healthcare Player with a 65.69% Potential Upside

Navigating the vast landscape of healthcare investments can be daunting, but Nutex Health Inc. (NUTX) offers a compelling case for investors seeking growth within the Medical..

Phibro Animal Health Corporation (PAHC): Investor Outlook Reveals 23.46% Upside Potential

Phibro Animal Health Corporation (NASDAQ: PAHC), with its roots tracing back to 1946, has grown into a formidable player in the healthcare sector, particularly within the..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 23.94% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector may find iRadimed Corporation (NASDAQ: IRMD) an intriguing prospect. With a market capitalization of $1.22 billion, this U.S.-based..

Enliven Therapeutics, Inc. (ELVN): Investor Outlook Highlights 23.98% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is rapidly emerging as a noteworthy player in the biotechnology sector, captivating investors with a compelling narrative centered on innovation and..

Weave Communications, Inc. (WEAV): Investor Outlook with 33% Upside Potential

Weave Communications, Inc. (NYSE: WEAV), a player in the healthcare sector specializing in health information services, presents an intriguing opportunity for investors looking to capitalize on..

Intellia Therapeutics, Inc. (NTLA)

⚠️ No article content returned.

..

Syndax Pharmaceuticals, Inc. (SNDX) Growth Potential: Analysts Forecast a 102.54% Upside

Investors with a keen eye on the biotechnology sector should take note of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a promising player in the healthcare industry. With..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Uncovering the Growth Potential in Biotech

Spyre Therapeutics, Inc. (SYRE) has emerged as a noteworthy contender in the biotechnology space, particularly for investors tracking the healthcare sector. With a focus on developing..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Analyzing a 19.76% Potential Upside in the Biotech Sector

Bicara Therapeutics Inc. (BCAX), a burgeoning name in the biotechnology sector, has been capturing investor interest with its promising clinical-stage pipeline focused on bifunctional therapies for..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 40% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX) stands at the forefront of the biopharmaceutical landscape, particularly within the biotechnology sector. With a compelling focus on the discovery and..

Cronos Group Inc. (CRON) Stock Analysis: Assessing Potential Amid Robust Revenue Growth

For investors keeping an eye on the burgeoning cannabis sector, Cronos Group Inc. (NASDAQ: CRON) presents a compelling case for consideration. Headquartered in Stayner, Canada, Cronos..

STAAR Surgical Company (STAA) Investor Outlook: Exploring Revenue Growth Amidst Volatility

STAAR Surgical Company (NASDAQ: STAA), a noteworthy player in the healthcare sector, specializes in the development and sale of implantable lenses for the eye, primarily targeting..

SI-BONE, Inc. (SIBN) Stock Analysis: Exploring a 35.88% Potential Upside with Strong Buy Consensus

SI-BONE, Inc. (NASDAQ: SIBN), a leading player in the healthcare sector specializing in innovative medical devices, is gaining investor attention with a robust potential upside of..

Ardelyx, Inc. (ARDX) Stock Analysis: Examining a Potential 223% Upside in the Biotechnology Sector

Investors with an eye on the biotechnology sector may find Ardelyx, Inc. (NASDAQ: ARDX) an intriguing opportunity, especially given its potential upside of 223.41%. As a..

Niagen Bioscience, Inc. (NAGE): Investor Outlook Highlights Potential 274% Upside

Niagen Bioscience, Inc. (NAGE), a burgeoning player in the biotechnology sector, is capturing investor attention with its significant potential for price appreciation. With a market capitalization..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Unveiling Near-Term Growth Potential with a 30% Upside

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is capturing investor attention with a compelling potential upside of 30.38%. Specializing in cancer therapies, this Hayward,..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Exploring a Promising 221% Upside in Biotech

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a San Diego-based biotechnology company, is capturing investor attention with its potential for significant upside. Specializing in the development of small-molecule..

RM Assessment sets out the case for wider digital exam adoption

RM Assessment outlines how fully digital exams could widen access, reduce manual processing and support the gradual modernisation of high-stakes assessment...
Search

Funds

July 31, 2026

RM Assessment sets out the case for wider digital exam adoption

RM Assessment outlines how fully digital exams could widen access, reduce manual processing and support the gradual modernisation of high-stakes assessment...
Search

Funds

July 31, 2026

FTSE 100

Funds